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Background: Acute mountain sickness (AMS) refers to the cerebral abnormalities typically triggered by exposure to
hypobaric hypoxia at high altitude. Although AMS is not often life threatening, it can seriously impact health quality
and decrease productivity. Thus, detection of potential susceptibility to AMS has become important for people
arriving at high-altitude plateaus for the first time, including laborers and military staff. The aim of this review was
to examine techniques which efficiently assess the susceptibility to AMS prior to exposure to high altitude.
Methods: By searching online databases, we retrieved studies with associations between AMS and methods to
detect the susceptible people who were not exposed to high altitudes. Studies reporting significant correlation
coefficients between screening methods and AMS scores were included.
Results: Several screening techniques of AMS susceptibility were found including cold pressor test, heart rate
variability, and lung functions. Of these markers, heart rate variability was positively associated with AMS scores,
while the rest were negatively associated with AMS scores.
Conclusions: We identified three physiological markers that were significantly associated with the risk of AMS.
Although it is well known that simple sea level tests are not really helpful in predicting AMS currently, these
markers, to some degree, may be employed as references in predicting susceptibility.
Keywords: Acute mountain sickness, Susceptibility, Screening techniquesBackground
Acute mountain sickness (AMS) describes the cerebral
syndromes that can develop in unacclimatized people
shortly after ascent to high altitude above 2500 m [1].
The reported prevalence of AMS varies widely because
of different ascent profiles. For example, in Summit
County of Colorado, the incidence of AMS was 22% at
altitudes of 1850–2750 m [2] and 42% when ascending
to 3000 m [3], and was as high as 75% of people
attempting ascent of Mount Kilimanjaro (5984 m) [4].
In laborers [5] and soldiers [6], the incidence of AMS
was much higher due to the requirements for laboring
or completion of missions under hypobaric hypoxia.
Under some conditions, AMS can result in oliguria, retinal
hemorrhage, ataxia, and coma [7], which can ultimately
proceed to life-threatening high altitude pulmonary edema
(HAPE) and high altitude cerebral edema [1]. With the* Correspondence: luowenj@fmmu.edu.cn; jy_chen@fmmu.edu.cn
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reproduction in any medium, provided the orincreasing demand for economic development, a large
number of people will be at risk of high altitude illness
when they first reach high altitude regions [8]. Thus, it is
critical to screen people with potential susceptibility to
AMS, particularly soldiers and workers, as they will be at
higher risk due to exercise in hypoxic conditions, which
was shown to increase the incidence and severity of AMS
compared with a similar sedentary trial [9].
Several risk factors for AMS have been identified, in-
cluding speed of ascent above 300 to 500 m per day in
the acclimatization period [10], previous history of AMS
or HAPE [11], obesity [12], migraine [13], persistence of
a patent foramen ovale [14], residence at an altitude
below 900 m [2], exertion [9], certain preexisting cardio-
pulmonary conditions [15], and various biochemical and
genetic factors [16]. However, the incidence and severity
of AMS not only depend on the above factors, but also
on the individual’s physiological susceptibility which
may as well associate with AMS [11]. Some physio-
logical parameters including arterial oxygen saturationtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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rely on pre-exposure to a high altitude or simulated
conditions. Nevertheless, it is inconvenient and unreal-
istic for people to experience exposure to hypobaric
hypoxia prior to going to high altitude for the first time.
Hence, our overall objective is to review the studies that
explored methods for prediction of AMS susceptibility
to develop rapid screening techniques for susceptible
subjects, though test results may have different meaning
for various sub-populations, not depending on pre-
exposure to altitude or simulated-altitude.
Methods
Searching strategy
In accordance with the preferred reporting items for
systematic reviews (PRISMA) statement [19], a comput-
erized literature search was performed within Medline
(PubMed), ISI web of science, EMBASE, Chinese Bio-
medical Disk, and the Chinese Journal Full-test Database
(up to April 2012). Both English and non-English language
articles were examined. The full text research articles
that could not be downloaded from the databases
were obtained via e-mail with the authors or by hand
searching.
The retrieval key words used were: Altitude Sickness,
hypoxia, susceptibility, and screening techniques.
Inclusion and exclusion criteria
Inclusion criteria:
1. Studies should report the detection of susceptibility
to AMS not depending on exposure of high altitude
or simulated.
2. Screening techniques should be convenient and have
low cost such as physiological parameters, which
could be used by large populations.
3. The sample size must be larger than 30 cases.
4. Results of the studies must include data representing
the association between score of AMS and predicted
methods, such as correlation efficient and P-value.
Exclusion criteria:
1. Animal experiment and unrelated studies, such as
pathological and physiological studies on the
association between AMS and its risk factor.
2. Screening methods rely on complicated and
inconvenient techniques such as detection of gene
polymorphism.
3. Study publications don’t contain the minimum
information necessary to obtain correlation efficient
and corresponding 95% confidence intervals.
4. Studies focused on detection of susceptibility to
AMS at high altitude or simulated.Definition of AMS
The Lake Louise scoring system, a well-validated standard
[20], was used for the diagnosis of AMS. Subjects with the
presence of headaches and at least 1 of the following
symptoms were determined to have AMS: gastrointestinal
upset (loss of appetite, nausea, and vomiting), fatigue/
weakness, dizziness/light-headedness, or insomnia (more
than just the usual frequent waking).Quality assessment of included studies
Two reviewers assessed quality of studies independently
using a tool based on the criteria described by Jadad for
prospective studies. Assessment discrepancies between the
reviewers were resolved through discussion and double-
check.
As for prospective study, the following items were
evaluated: (1) randomization procedures, (2) matching
procedures, (3) blinding procedures, (4) analysis of drop-
outs, (5) reliability and validity of assessment instruments,
(6) control for cointerventions, (7) comparability of base-
line patient characteristics, (8) control for amount of ther-
apy, and (9) applied statistics etc.Results
From 198 retrieval studies, 5 studies from China and
Nepal were finally included (Figure 1). Data in all included
studies were obtained through following up and during
process of research both researchers and subjects were
exposed to hypobaric hypoxia.General characteristics
Table 1 presents the characteristics of included studies.
All studies had a prospective longitudinal design: one
was from Nepal, the rest were from China, where abun-
dant territory belongs to high altitude mountain or
plateau and only one used the hypobaric chambers to
stimulate the true environment. Altitude of departure
were all less largely than destination. Sample size,
though large than 30, was less than other clinical studies
and volunteers and soldiers, in whom males took advan-
tages, were main subjects. However, the intervals of ages
of subjects reported by Huang LL et al. [21] were
30 years old larger than the others. Among the five
studies focused on detection of susceptibility to AMS,
two on HRV, two on CPT and two on lung functions.
Furthermore, Lake Louise scoring system, a well-
validated standard, was used for the diagnosis by Huang
LL et al. [21] and Diagnostic Criteria of High Altitude
Disease in China, which was brought into effect in
China during the 1990s and introduced to the world
through translation by John B. West in 2010, was
employed by the remaining studies.
Studies form databases of Medline, ISI web of 
science and EMBASE, Chinese Biomedical Disk,
and Chinese Journal Full-test Database (n=198)
Exclude the repeated studies appeared in both 
databases (n=126)
The studies with detailed information about  
detection of susceptibility of AMS (n=53)
Eliminate the following studies:
1 Review (n=11);
2 Studies that relying on exposure to high altitude or
simulated (n=37).  
Included studies (n=5) 
Eliminate the unrelated 
studies (n=73)
Figure 1 The flow chart.
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The quality scores of the included studies are summa-
rized in Table 2. Because of research difficulties and
considerations of ethics, the included population stud-
ies about effects of high altitude exposure on human
bodies were basically belonged to quasi-experiment
compared with randomized controlled trials. There-
fore, evidence degree was lower than randomized con-
trolled trials but higher than observational studies.
Further, due to lack of experimental controls, the five
studies totally employed own controls before and after





















242 m 4500 m 43 Soldiers M
Zhou QQ
[25]
Tibet 300 3685 m 113 Soldiers M
Wang L
[46]
Tibet 1500 4900 m 60 Soldiers M
Abbreviations: L Lake Louise scoring system, a well-validated standard, C Diagnostic
China during the 1990s and introduced to the world through translation by John BTest procedure
The cold pressor test (CPT) is a standardized procedure
initially used to induce a cardiovascular response in
humans [22]. Subjects are asked to immerse one hand
to just above the wrist for 1 min in ice water (4-5°C; 39-
41°F). During this period, blood pressure is recorded on
the opposite arm at 15 s intervals, and the highest read-
ing designated the peak or ceiling blood pressure. The
difference between peak and basal blood pressures de-
termines the level of vascular reactivity [23].
Heart rate variability (HRV) is assessed in the partici-









49.3 ± 2.3 HRV L Odds Ration <0.05
ales 18.2 ± 0.8 HRV & CPT C Correlation
coefficient
<0.01
ales 19.02 ± 0.96 CPT C t value <0.05
ales 19 ± 1 FEV1 C Correlation
coefficient
<0.01
ales 19.8 FVC/BSA C t value <0.01
Criteria of High Altitude Disease in China, which was brought into effect in
. West in 2010.
Table 2 Quality assessment of included studies
Trials Criteria Total score
A B C D E F G H I J K L M N O P Q R S T U V W X
Huang HH [21] 0 0 1 0 1 0 1 1 0 1 1 1 1 0 0 0 1 1 1 0 1 12 9 1.33
Tian KX [35] 0 0 1 0 1 0 1 1 0 1 1 1 1 0 0 0 1 1 1 1 1 13 8 1.63
Long M [29] 0 0 1 0 1 0 1 1 0 1 1 1 1 0 0 0 0 1 1 0 1 11 10 1.1
Zhou QQ [25] 0 0 1 0 1 0 1 1 0 1 1 1 1 0 0 0 1 1 1 1 1 12 9 1.33
Wang L [46] 0 0 1 0 1 0 1 1 0 1 1 1 1 0 0 0 0 1 1 0 1 11 10 1.1
Abbreviations: A Randomized controlled trial, B Method of randomization appropriate, C Study prospective, D Double-blind, E Inclusion and exclusion criteria,
F Method of double-blinding appropriate, G Participants selection described, H Comparison of treatment and control or before experiment and after, I Description
of withdrawals, J Models adequate, K Objectives defined, L Outcome defined, M Sample size justified, N Description of the co-interventions, O Other care identical,
P Source of bias addressed, Q Raw data available, R Statistical methods described, S Published (not just abstract), T Financial support described, U quasi-
experiment, V Number of yes, W Number of no, X Ratio yes/no, 1 yes, 0 no/not mentioned, N not applicable.
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participants wear a chest strap from a heart-rate monitor
watch. After a 5-min rest period, heart rate is collected on
a beat-by-beat basis for 10 min. HRV consists of a stand-
ard time domain including the standard deviation of R-R
intervals, the root mean square of the mean differences in
successive R-R intervals, and the percentage of successive
R-R intervals that differs by more than 50 ms. Frequency
domain analysis is performed by using nonparametric fast
Fourier transform and autoregressive modeling, which
contains spectral powers at low frequency (LF), high fre-
quency (HF), very low frequency and total power [24].
Pulmonary functions are tested with Sensor Medics
Vmax229D Pulmonary function instrument. Standardized
gas is employed to determine the standard before test.
Detection index includes flow-volume loop, maximal
voluntary ventilation, forced expiratory volume in 1 second
(FEV1), forced vital capacity (FVC) and peak expiratory
flow. Each measure is repeated twice, and the average value
for statistical analysis [25].
Discussion
Autonomic nervous system
A marked increase in peripheral sympathetic activity is a
common feature of mountain sickness [26]. Increased
sympathetic activity is part of the integrated physiological
response to a hypoxic stimulus [27]. Interestingly, subjects
with AMS had an abnormal pattern of cardiovascular vari-
ability compared with subjects without AMS [28]. Thus,
assessment of the degree of sympathetic activity of the
automatic nervous system may be used to evaluate suscep-
tibility to AMS [29].
Cold pressor test
The cold pressor test (CPT) involves placing a hand or
forearm in cold water, a stimulus that produces a slowly
mounting pain of mild to moderate intensity, and being
terminated by voluntary withdrawal of the limb. The CPT
has been used in many studies of pain, autonomic reactiv-
ity, and hormonal stress responses [30]. This acute stresstest used to evaluate the initial hemodynamic response to
a stimulus also represents an index of integrity of sympa-
thetic functions at the efferent level. For example, CPT
was reported to induce a large sympathetic discharge in
the spinal cord and terminal endings of the sympathetic
nervous system [31]. Thus, CPT is widely used to evaluate
the sympathetic neural influence on circulation in normal
humans [32].
In healthy populations, the hemodynamic changes ob-
served in response to CPT were similar when measured
at sea level and after ascending to high altitude [33].
Viswanathan originally reported that blood pressure
changes could be used to predict AMS with CPT [34].
Meanwhile a more recent study reported that subjects
unsusceptible to AMS exhibited a higher blood pressure
and heart rate response to CPT (r = −0.35, P = 0.01).
This study found that CPT in 99 healthy young males
was examined at plain and their AMS scores were inves-
tigated in successive 5 days after exposure. The increase
in heart rate was less in moderate to severe AMS group
[(7.57 ± 8.22)b/min] than in very little response group
[(25.47 ± 19.26)b/min)] after CPT (P < 0.05) [35]. It seemed
that autonomic nervous system (ANS) reflected by CPT
response played an important role in the progress of the
AMS. Function of ANS may be inhibited after exposure to
high altitude and subjects with weaker ability of ANS
regulation were prone to be susceptible to AMS. Test of
ANS with CPT may be helpful in distinguishing suscep-
tible ones at lower altitudes. Also, another study found
that there existed significant differences of CPT before
entering stimulated high altitude between AMS and non-
AMS [29]. Thus, further studies on the use of CPT for
evaluation the risk of AMS are required.
Heart rate variability
The autonomic nervous system plays a role in the
modulation of the oscillatory behavior of the cardiovas-
cular system [36]. Power spectral analysis of HRV, a new
noninvasive measurement to evaluate the sympathovagal
balance between the sympathetic and parasympathetic
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tify these oscillatory components. Specific spectral com-
ponents of HRV are considered to be associated with
autonomic modulation of the heart [38]. In addition,
increased sympathetic activity during acute exposure to
hypobaric hypoxia at high altitude is a common presen-
tation of AMS. Thus, some studies, as depicted below,
have explored whether the sequential changes of specific
spectral components of HRV could be used as an early
prediction for the presentation of AMS after trekking
from sea level via low to high altitude.
The time domain and frequency domain in HRV could
change significantly after simulated or actual high alti-
tude exposure [28,39]. Further, significant differences
were found in total variance of R-R interval at high alti-
tude between subjects with and without AMS [28]. HRV
also plays an important role in predicting AMS at low
altitude. For example, Huang et al. reported that subjects
with both HF% <20% and a LF: HF ratio >1.3 measured
at 1317 m had an odds ratio of 7.00 (95% confidence
interval, 1.11-44.06; P = 0.047) for developing AMS at
3440 m. A total of 32 subjects (10 men and 22 women)
were recruited and a 12-day itinerary by trekking to the
Namche Bazaar in Nepal in this study. It may implicate
that predominantly sympathetic modulation on the heart
in the exposure of mild hypoxia may be prone to suffer-
ing AMS in more severe hypoxic condition. The sug-
gested reasonable low altitude measurement of HRV
that would be useful in predicting the risk of AMS at
high altitudes would be around the height of 1300 m to
1400 m [21].
Similar results were reported by Tian et al. [35], where
trend of LF/HF and normalized LF decreased associated
with lower AMS scores and normalized HF increased
along with higher AMS scores, found that AMS was
positively correlated with LF:HF (r = 0.437, P < 0.01). The
LF/HF ratio has gained wide acceptance as a tool to assess
cardiovascular autonomic regulation where increases in
LF/HF are assumed to reflect a shift to “sympathetic
dominance” and decreases in this index correspond to a
“parasympathetic dominance [40]”. Thus, the positive
relationship may be explained by that people with dom-
inant sympathetic activity at plain would be more sus-
ceptible to AMS. Overall, these data suggest that HRV
might be useful for screening of people at risk for AMS.
Pulmonary functions
A drop in the oxygen pressure of the arterial blood leads
to hypoxic stimulation of peripheral chemoreceptors
primarily in the carotid and aortic bodies, causing an in-
crease in alveolar oxygen pressure and arterial oxygen
pressure. This effect is known as the hypoxic ventilatory
response [41], and the involuntary increase in the venti-
latory response is by far the most important feature ofacclimatization [42]. Bartsch et al. also reported that
alveolar–arterial oxygen pressure difference was higher,
and arterial oxygen pressure was lower, in AMS subjects
compared to controls, suggesting pulmonary dysfunc-
tion in AMS [43]. Further, two previous studies found
decreased vital capacity with preserved FEV1/FVC ratios
in subjects with AMS [44,45]. Nevertheless, few studies
have utilized the pulmonary functional parameters such as
FEV1 and FVC in predicting AMS at sea level. As an
example, Zhou et al. showed that FEV1 was negatively
correlated with the AMS score (r = −0.244, P = 0.009). In
this study, 113 males were recruited from their native
places in plain. Their lung function was determined at the
altitude of 300 m before air transportation. Scores of AMS
were recorded by medical staffs 2 or 3 days after their
arrival at the altitude of 3 658 m and correlative analysis
of each lung functional index and scores of AMS was sub-
sequently conducted [25]. Another study found that FVC/
body surface area (BSA) had the predicted role when
FVC/BSA > 3 liter per square meter [46]. Many studies
have also used limited samples sizes because of the diffi-
culty in transporting people to high altitude. Nevertheless,
overall these data suggest that pulmonary functions, which
partly decide hyperventilatory capacity, may be used to
predict altitude sickness [47].
Other methods and limitations
Other methods for predicting AMS not included in this
study have been reported. For example, Missoum et al.
found that anxiety prior to ascent could predict AMS
symptoms psychologically [48]. However, the question-
naires and scales used for measuring anxiety in that study
were not sensitive to the symptoms of clinical anxiety and
panic [49]. Other studies have examined indicators of
AMS during ascent exposed to hypobaric conditions such
as arterial oxygen saturation [50]. Although these parame-
ters are more accurate as they were tested in actual or
simulated situations, the costs of such studies are high.
Nevertheless, such indexes may be used to monitor for
AMS during transport to altitude to allow prompt treat-
ment in susceptible people [51].
There are several limitations of our study. Our indicative
system may not reflect the full ability of adaption to hyp-
oxemia as other indicators may have been overlooked.
Further, when constructing a predictive model, there may
exist colinearity between parameters such as CPT and
HRV, which are both autonomic nervous system indica-
tors. This potential bias may reduce the accuracy of pre-
dictions for AMS.
Conclusions
In this review, we found three significant markers includ-
ing, CPT, HRV and lung functions, to some degree, may
be employed as references in predicting susceptibility,
Table 3 Correlation coefficients between indicators and
AMS
Parameters Correlation coefficient (r) P value Instructions
Cold pressor test −0.35 0.01 Published
Heart rate variability 0.437 <0.01 Published
Lung functions −0.244 0.009 Published
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in predicting AMS to date without reliance on simulated
or actual exposure to high altitudes (Table 3). Further,
we should also highlight that these associations were
weak because all correlation coefficients in the analyzed
studies were under 0.5. Future studies should explore
two aspects to decide whether these physiological vari-
ables were effective or not. Firstly, we should find
whether these three markers of susceptible subjects
could be turned into the normal level of unsusceptible
ones after taking some medicine which could prevent or
cure AMS. In addition, prospective cohort studies may
be carried out to ensure practicability and feasibility of
these variables which may also be utilized to develop a
mathematical predictive model.
From a public health perspective, our goal is to develop
simple and rapid screening tests for assessing susceptibility
to AMS and to be used in people that will work or be
deployed to complete missions at high altitudes. Thus,
these indicators must objectively reflect the ability of re-
sistance to hypoxia, while the methods should be conveni-
ent and have low cost [52]. Finally, these findings might
provide a valuable reference to guide highland health ser-
vices so that medical cost may be reduced and life quality
of subjects may be improved.
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